SEC Filings

SEC Filings

Filing date	Form	Description	View
Jul 10, 2019	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001603756-19-000028.pdf 0001603756-19-000028.rtf 0001603756-19-000028.xls
Jun 22, 2020	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001603756-20-000055.pdf 0001603756-20-000055.rtf 0001603756-20-000055.xls
May 13, 2022	DEFR14A	DEFR14A	View HTML 0001603756-22-000037.pdf 0001603756-22-000037.rtf 0001603756-22-000037.xls
Aug 28, 2018	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	View HTML 0000950123-18-009165.pdf 0000950123-18-009165.rtf 0000950123-18-009165.xls
Oct 30, 2018	EFFECT	EFFECT	View HTML 9999999995-18-002758.pdf 9999999995-18-002758.rtf
Nov 18, 2019	EFFECT	EFFECT	View HTML 9999999995-19-002601.pdf 9999999995-19-002601.rtf
Apr 05, 2022	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0001603756-22-000021.pdf 0001603756-22-000021.rtf 0001603756-22-000021.xls
Oct 05, 2018	S-1	Registration statement for face-amount certificate companies	View HTML 0001193125-18-294804.pdf 0001193125-18-294804.rtf 0001193125-18-294804.xls
Oct 22, 2018	S-1/A	Amended Registration statement for face-amount certificate companies	View HTML 0001193125-18-303533.pdf 0001193125-18-303533.rtf 0001193125-18-303533.xls
Oct 25, 2018	S-1/A	Amended Registration statement for face-amount certificate companies	View HTML 0001193125-18-307791.pdf 0001193125-18-307791.rtf 0001193125-18-307791.xls

Data provided by Kaleidoscope.

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US